RayKnowChina Research Map
Shortlist

Xining

Affiliated Hospital of Qinghai University

青海大学附属医院

Listed for 8 of the 53 diseases this site covers, from the research papers it led and the trials registered with it as lead sponsor or site.

Research activity in public records, not a rating of care. Whether the hospital can help a particular patient is for the hospital and the treating doctor to say.

No official website checked for this hospital yet.

Getting in touch

Research at Affiliated Hospital of Qinghai University

Choose a disease to see the papers and trials behind it. Each tile shows papers led, 2021–2025, and papers per year.

Only the 53 diseases this site covers. A disease it is not listed for means this hospital did not meet the listing rule for that disease in these records; it does not mean the hospital does not treat it. Which hospitals are listed

  1. Stomach cancer胃癌16 papers led
  2. Osteosarcoma骨肉瘤3 papers led
  3. Gastrointestinal stromal tumour胃肠道间质瘤1 paper led
  4. Ewing sarcoma尤文肉瘤1 paper led
  5. Multiple myeloma多发性骨髓瘤1 paper led1 open trial led
  6. Aplastic anaemia再生障碍性贫血0 papers led1 open trial led
  7. Hepatic echinococcosis肝包虫病21 papers led
  8. Primary sclerosing cholangitis原发性硬化性胆管炎0 papers led

Not listed for: Nasopharyngeal carcinoma, Oesophageal squamous cell carcinoma, Hepatocellular carcinoma, Hepatoblastoma, Retinoblastoma, Chordoma, Neuroblastoma, B-cell acute lymphoblastic leukaemia, Haemophagocytic lymphohistiocytosis, Beta thalassaemia, Haemophilia A, Atypical haemolytic uraemic syndrome, Thrombotic thrombocytopenic purpura, Fanconi anaemia, Neuromyelitis optica spectrum disorder, IgG4-related disease, Myasthenia gravis, Moyamoya disease, Wilson disease, Biliary atresia, Anti-NMDA receptor encephalitis, Takayasu arteritis, Idiopathic pulmonary fibrosis, Lymphangioleiomyomatosis, Amyotrophic lateral sclerosis, Spinal muscular atrophy, Fabry disease, Pompe disease, Duchenne muscular dystrophy, Behçet disease, Alport syndrome, IgA nephropathy, Gaucher disease, Niemann–Pick disease type C, Osteogenesis imperfecta, Primary biliary cholangitis, Congenital diaphragmatic hernia, Hirschsprung disease, Inherited epidermolysis bullosa, Hereditary angioedema, Familial adenomatous polyposis, Leber hereditary optic neuropathy, Majeed syndrome, NGLY1 deficiency, ISG15 deficiency.

Cancer

Stomach cancer

胃癌

Led 16 of the 9,782 English-language PubMed papers on stomach cancer with an author in mainland China, 2021–2025: 0.2%.

Papers led
16
2021–2025
Trials led
6
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
2
led by another institution
Papers led per year
2021: 0020212022: 5520222023: 3320232024: 2220242025: 552025

3 hospitals in Xining for stomach cancer211 hospitals in China for stomach cancer

Open trials with this hospital 2

Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 8 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.

  1. Recruiting
    A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
    Phase
    Phase 3
    Started
    2025-05
    Registry
    NCT06901531

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 13 listed hospitals as study sitesBeijing, Chengdu, Fuzhou, Hangzhou, Harbin, Hefei, Shanghai, Shijiazhuang, Tianjin, Wuhan, Xining, Zhengzhou

  2. Recruiting
    A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
    Phase
    Phase 3
    Started
    2024-11
    Registry
    NCT06532006

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 36 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Changzhou, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Lanzhou, Luoyang, Nanchang, Nanjing, Qingdao, Shanghai, Shijiazhuang, Taiyuan, Tianjin, Urumqi, Xiamen, Xining, Xuzhou, Yinchuan, Zhengzhou

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

The records behind these numbers
ThemesChemotherapy & combined treatmentSurgeryPeritoneal spread & advanced disease
Departments in papersMedical oncologyGastroenterology / hepatologyPathology / laboratory medicineRadiology / nuclear medicine

Hospital name read automatically from author addresses, not yet checked by hand.

Papers it led16
  1. Elp3 activates the JNK/MAPK pathway through histone acetylation to promote gastric cancer proliferation, migration, and invasion.2026Histology and histopathology
  2. Incidence and risk factors of sarcopenia in gastric cancer patients: a meta-analysis and systematic review.2025BMC cancerFree full text
  3. Interaction Between Hypoxia-Inducible Factor 1-alpha Gene Polymorphism and Helicobacter pylori Infection on Gastric Cancer in a Chinese Tibetan Population.2025Biochemical genetics
  4. TPM4 influences the initiation and progression of gastric cancer by modulating ferroptosis via SCD1.2025Clinical and experimental medicineFree full text
  5. Multiple Gastric Schwannoma: A Case Report.2025Current medical imagingFree full text
  6. The albumin-myosteatosis gauge predicts the response to neoadjuvant chemotherapy for locally advanced gastric cancer.2025Surgery today
  7. Crocin Combined with Cisplatin Regulates Proliferation, Apoptosis, and EMT of Gastric Cancer Cells via the FGFR3/MAPK/ERK Pathway In vitro and In vivo.2024Current cancer drug targets
  8. The correlation between systemic inflammatory markers and efficiency for advanced gastric cancer patients treated with ICIs combined with chemotherapy.2024Immunology
  9. Analysis of the efficacy and influencing factors of preoperative P-SOX neoadjuvant chemotherapy regimen for progressive gastric cancer-construction of a clinical prediction model.2023Cancer medicine
  10. Integrated pan-cancer analysis and experimental verification of the roles of tropomyosin 4 in gastric cancer.2023Frontiers in immunologyFree full text
  11. Correlation between mismatch repair and survival of patients with gastric cancer after 5-FU-based adjuvant chemotherapy.2023Journal of gastroenterology
  12. Male-specific long non-coding RNA testis-specific transcript, Y-linked 15 promotes gastric cancer cell growth by regulating Wnt family member 1/β-catenin signaling by sponging microRNA let-7a-5p.2022BioengineeredFree full text
  13. Efficacy and safety evaluation of PSOX, DOF and SOX regimens as neoadjuvant chemotherapy for advanced gastric cancer.2022Future oncology (London, England)
  14. Comparison of incidence and prognosis between young and old gastric cancer patient in North-Western China: A retrospective cohort study.2022MedicineFree full text
  15. Correlations of preoperative systematic immuno-inflammatory index and prognostic nutrition index with a prognosis of patients after radical gastric cancer surgery.2022Surgery
  16. Correlation analysis between preoperative systemic immune inflammation index and prognosis of patients after radical gastric cancer surgery: based on propensity score matching method.2022World journal of surgical oncologyFree full text
All its trials on ClinicalTrials.gov, any status12
  1. Comparing the Prognosis of Patients With Cardia and Non-cardia Gastric Cancer.Status unknownNCT03895008Lead sponsorStart 2019-07
  2. Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric CancerStatus unknownNCT03957564Lead sponsorPhase 2Start 2019-05
  3. Apatinib for the Elderly Advanced Gastric CancerCompletedNCT03104283Lead sponsorPhase 2Start 2017-06
  4. Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric CancerStatus unknownNCT03263741Lead sponsorPhase 2Start 2017-04
  5. The Relationship Between Microsatellite Instability and Efficacy of Fluorouracil Based Adjuvant Chemotherapy in Gastric Cancer After OperationCompletedNCT03485196Lead sponsorStart 2017-03
  6. A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) CancerStatus unknownNCT05216237Lead (inferred)Phase 2Start 2022-02
  7. A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerRecruitingNCT06901531Study sitePhase 3Start 2025-05
  8. A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric CancerRecruitingNCT06532006Study sitePhase 3Start 2024-11
  9. A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-OverexpressionStatus unknownNCT04714190Study sitePhase 3Start 2021-03
  10. A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer DiagnosisStatus unknownNCT04440605Study siteStart 2020-07
  11. Incidence of Pancreatic Fistula After Radical GastrectomyStatus unknownNCT03391687Study siteStart 2017-12
  12. Study on Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Advanced Gastric CancerStatus unknownNCT02845986Study sitePhase 2Start 2016-09

Run the PubMed searchClinicalTrials.gov

Cancer

Osteosarcoma

骨肉瘤

Led 3 of the 2,257 English-language PubMed papers on osteosarcoma with an author in mainland China, 2021–2025: 0.1%.

Papers led
3
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 3320212022: 0020222023: 0020232024: 0020242025: 002025

4 hospitals in Xining for osteosarcoma570 hospitals in China for osteosarcoma

No open trial on osteosarcoma lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

Run the PubMed searchClinicalTrials.gov

Cancer

Gastrointestinal stromal tumour

胃肠道间质瘤

Led 1 of the 523 English-language PubMed papers on gastrointestinal stromal tumour with an author in mainland China, 2021–2025: 0.2%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 1120232024: 0020242025: 002025

2 hospitals in Xining for gastrointestinal stromal tumour240 hospitals in China for gastrointestinal stromal tumour

No open trial on gastrointestinal stromal tumour lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

Run the PubMed searchClinicalTrials.gov

Cancer

Ewing sarcoma

尤文肉瘤

Led 1 of the 163 English-language PubMed papers on Ewing sarcoma with an author in mainland China, 2021–2025: 0.6%.

Papers led
1
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 1120212022: 0020222023: 0020232024: 0020242025: 002025

2 hospitals in Xining for Ewing sarcoma134 hospitals in China for Ewing sarcoma

No open trial on Ewing sarcoma lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

Papers it led1
  1. An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning.2021Journal of cancer research and clinical oncology

Run the PubMed searchClinicalTrials.gov

Blood disorders

Multiple myeloma

多发性骨髓瘤

Led 1 of the 1,676 English-language PubMed papers on multiple myeloma with an author in mainland China, 2021–2025: 0.06%.

Papers led
1
2021–2025
Trials led
1
any status, ClinicalTrials.gov
Open trials led
1
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 0020212022: 0020222023: 0020232024: 0020242025: 112025

1 hospital in Xining for multiple myeloma175 hospitals in China for multiple myeloma

Open trials with this hospital 1

Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 8 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.

  1. Recruiting
    High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
    Phase
    Not given
    Started
    2023-09
    Registry
    NCT07205523

    Age not stated (registered criteria)

    Led by Affiliated Hospital of Qinghai UniversityXining

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

The records behind these numbers
ThemesDiagnosis, MRD & risk

Hospital name read automatically from author addresses, not yet checked by hand.

Run the PubMed searchClinicalTrials.gov

Blood disorders

Aplastic anaemia

再生障碍性贫血

Led no English-language PubMed papers on aplastic anaemia in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
1
any status, ClinicalTrials.gov
Open trials led
1
recruiting or about to
Open trials as a site
0
led by another institution

1 hospital in Xining for aplastic anaemia63 hospitals in China for aplastic anaemia

Open trials with this hospital 1

Recruiting, not yet recruiting, or by invitation on ClinicalTrials.gov on 8 Nov 2026. Trials registered only in China’s own registry (ChiCTR) are not included. Whether someone can take part is decided by the study team.

  1. Recruiting
    High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
    Phase
    Not given
    Started
    2023-09
    Registry
    NCT07205523

    Age not stated (registered criteria)

    Led by Affiliated Hospital of Qinghai UniversityXining

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

The records behind these numbers

Hospital name read automatically from author addresses, not yet checked by hand.

All its trials on ClinicalTrials.gov, any status1
  1. High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)RecruitingNCT07205523Lead (inferred)Start 2023-09

Run the PubMed searchClinicalTrials.gov

Other diseases

Hepatic echinococcosis

肝包虫病

Led 21 of the 152 English-language PubMed papers on hepatic echinococcosis with an author in mainland China, 2021–2025: 13.8%.

Papers led
21
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution
Papers led per year
2021: 2220212022: 5520222023: 4420232024: 5520242025: 552025

3 hospitals in Xining for hepatic echinococcosis44 hospitals in China for hepatic echinococcosis

No open trial on hepatic echinococcosis lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersSurgery (general/hepatobiliary/pancreatic)Radiology / nuclear medicinePediatrics

Hospital name read automatically from author addresses, not yet checked by hand.

Papers it led21
  1. Activation of the Wnt signaling pathway and its role in epithelial-mesenchymal transition and hepatic fibrosis in alveolar echinococcosis.2025Frontiers in cellular and infection microbiology
  2. Analysis of risk factors and development of a predictive model for postoperative pulmonary complications in hepatic echinococcosis patients.2025Scientific reports
  3. The value of nomogram analysis in predicting pulmonary metastasis in hepatic alveolar echinococcosis.2025Scientific reports
  4. Identification of lesion bioactivity in hepatic cystic echinococcosis using a transformer-based fusion model.2025The Journal of infection
  5. Clinical application value of droplet digital PCR detection of Em-cfDNA in the diagnosis of hepatic alveolar echinococcosis.2025Travel medicine and infectious disease
  6. The value of nomogram analysis in prediction of cerebral spread of hepatic alveolar echinococcosis.2024Acta tropica
  7. Metabolic mechanism and pharmacological study of albendazole in secondary hepatic alveolar echinococcosis (HAE) model rats.2024Antimicrobial agents and chemotherapy
  8. Molecular analyses of exosome-derived miRNAs revealed reduced expression of miR-184-3p and decreased exosome concentration in patients with alveolar echinococcosis.2024Experimental parasitology
  9. The expression of CTLA-4 in hepatic alveolar echinococcosis patients and blocking CTLA-4 to reverse T cell exhaustion in Echinococcus multilocularis-infected mice.2024Frontiers in immunology
  10. Comparison of treatment efficiency of percutaneous transhepatic biliary drainage and endoscopic retrograde cholangiopancreatography for non-surgical hepatic alveolar echinococcosis patients suffered from jaundice: exploration from a single 2024Minerva surgery
  11. Research progress in the proteomics of Echinococcus multilocularis and alveolar echinococcosis.2023Asian journal of surgery
  12. Kidney invasion occurred 2 years following liver transplantation for hepatic alveolar echinococcosis: a case report.2023BMC infectious diseases
  13. Detection and subtyping of hepatic echinococcosis from plain CT images with deep learning: a retrospective, multicentre study.2023The Lancet. Digital health
  14. Effect and mechanism of reactive oxygen species-mediated NOD-like receptor family pyrin domain-containing 3 inflammasome activation in hepatic alveolar echinococcosis.2023World journal of gastroenterology
  15. Analysis of the efficacy of microwave ablation in the treatment of early hepatic alveolar echinococcosis: A propensity score matching based study.2022Acta tropica
  16. Risk factors for post-endoscopic retrograde cholangiopancreatography cholangitis in patients with hepatic alveolar echinococcosis-an observational study.2022Annals of medicine
  17. Effectiveness and safety of ultrasound-guided percutaneous microwave ablation for hepatic alveolar echinococcosis.2022BMC medical imaging
  18. CLINICAL SIGNIFICANCE AND CORRELATION ANALYSIS OF SERUM FERRITIN IN PATIENTS WITH HEPATIC ALVEOLAR ECHINOCOCCOSIS.2022The Journal of parasitology
  19. 7T Small Animal MRI Research for Hepatic Alveolar Echinococcosis.2022Topics in magnetic resonance imaging : TMRI
  20. Improvement of the Bioavailability and Anti-hepatic Alveolar Echinococcosis Effect of Albendazole-Isethionate/Hypromellose Acetate Succinate (HPMC-AS) Complex.2021Antimicrobial agents and chemotherapy
  21. A Case of Human Hepatic Alveolar Echinococcosis Accompanied by Lung and Brain Metastases.2021The Korean journal of parasitology
Chinese-language papers (not in the count)4
  1. [Expression of neutrophil extracellular traps and phagocytic functions among patients with hepatic alveolar echinococcosis].2024Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
  2. [Hepatic cystic echinococcosis complicated with tuberculous empyema misdiagnosed as hepatic and pulmonary cystic echinococcosis: one case report].2022Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
  3. [Corrosive sclerosing cholangitis after surgical treatment of hepatic cystic echinococcosis: a case report].2022Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
  4. [Primary liver cancer complicated by hepatic cystic echinococcosis: a case report].2021Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
Earlier papers (2016–2020)11
  1. Nutritional status and screening tools to detect nutritional risk in hospitalized patients with hepatic echinococcosis.2020Parasite (Paris, France)
  2. Diagnosis and treatment of a case of hepatic mixed echinococcosis infection combined with distant organ metastasis.2020The Journal of international medical research
  3. Nomogram Analysis and Internal Validation to Predict the Risk of Cystobiliary Communication in Patients Undergoing Hydatid Liver Cyst Surgery.2020World journal of surgery
  4. [Progress of researches on the use of ultrasound in the diagnosis and treatment of hepatic alveolar echinococcosis].2020Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
  5. Treatment of hepatic alveolar echinococcosis infringing the inferior vena cava.2019Revista da Sociedade Brasileira de Medicina Tropical
  6. A new treatment strategy for end-stage hepatic alveolar echinococcosis: IVC resection without reconstruction.2019Scientific reports
  7. [Value of magnetic resonance imaging in assessment of iron deposition among patients with hepatic alveolar echinococcosis: a preliminary evaluation].2019Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
  8. [Clinical characteristics of 175 cases with advanced hepatic alveolar echinococcosis].2019Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
  9. [Cloning, expression and immunity analysis of transketolase of Echinococcus granulosus].2018Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control
  10. Combined resection of the right liver lobe and retrohepatic inferior vena cava to treat hepatic alveolar echinococcosis: A case report.2017Medicine
  11. Efficacy and safety of ultrasound-guided percutaneous microwave ablation for the treatment of hepatic alveolar echinococcosis: A preliminary study.2017Medicine

Run the PubMed searchClinicalTrials.gov

Other diseases

Primary sclerosing cholangitis

原发性硬化性胆管炎

Led no English-language PubMed papers on primary sclerosing cholangitis in 2021–2025. Its linked research records are below.

Papers led
0
2021–2025
Trials led
0
any status, ClinicalTrials.gov
Open trials led
0
recruiting or about to
Open trials as a site
0
led by another institution

1 hospital in Xining for primary sclerosing cholangitis89 hospitals in China for primary sclerosing cholangitis

No open trial on primary sclerosing cholangitis lists this hospital on ClinicalTrials.gov on 13 Nov 2026.

The records behind these numbers
Departments in papersSurgery (general/hepatobiliary/pancreatic)

Hospital name read automatically from author addresses, not yet checked by hand.

Chinese-language papers (not in the count)1
  1. [Corrosive sclerosing cholangitis after surgical treatment of hepatic cystic echinococcosis: a case report].2022Zhongguo xue xi chong bing fang zhi za zhi = Chinese journal of schistosomiasis control

Run the PubMed searchClinicalTrials.gov

Other linked evidence

Getting in touch

Name card to show staff or a driver

青海大学附属医院

Affiliated Hospital of Qinghai University

西宁

Large hospitals often have several campuses. Confirm the campus with the hospital before travelling.

Inquiry letter in English and Chinese

Fill in the brackets, then send it through the contact options on the hospital's international office or official website. Nothing typed here leaves this device.

Records hospitals usually ask for

  • A recent summary or letter from the treating doctor
  • Pathology report
  • Scans (CT, MRI, PET) with their reports, and the images if possible
  • Treatments so far, with dates
  • Current medicines

What to do next

Talk with the treating doctorThis page can be shared with the treating doctor to discuss whether this team's work is relevant.
Check the team is still therePapers lag by months and doctors move. Look for the department on the hospital's own website.
Contact the hospital directlyUse the hospital's own contacts. Hospitals never pay us, and each hospital decides which patients it accepts.

Where these numbers come from

Papers

English-language PubMed papers whose first or last author lists this hospital as their first affiliation, 2021–2025. Definitions

Trials

ClinicalTrials.gov records naming this hospital as lead sponsor or site, as of 8 Nov 2026.

Identifiers and other names

No hospital-level ROR record matched.

Suggest a correctionDownload the data